These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2309295)

  • 1. Renal replacement therapy in the cyclosporine era: results of a national transplantation program.
    Albrechtsen D; Berg KJ; Brekke I; Fauchald P; Jakobsen A; Sødal G; Talseth T; Leivestad T; Flatmark A
    Transplant Proc; 1990 Feb; 22(1):155-6. PubMed ID: 2309295
    [No Abstract]   [Full Text] [Related]  

  • 2. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of cyclosporine A on the DRw6 effect in renal transplantation.
    Hendriks GF; de Lange P; Schreuder GM; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):650-1. PubMed ID: 3274832
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal allograft survival in highly sensitized patients treated with cyclosporine.
    Doran M; Coppage M; Ruth J; Fish J; Winsett O; Vaidya S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1988. PubMed ID: 3274458
    [No Abstract]   [Full Text] [Related]  

  • 5. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
    Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
    Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
    [No Abstract]   [Full Text] [Related]  

  • 7. Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years.
    Alexander JW; Vaughn WK; Pfaff WW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):672-4. PubMed ID: 3274836
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF; de Lange P; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney retransplantation in the cyclosporine era.
    Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
    Mieny CJ; Nel PJ; Becker JH; Pretorius JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1852. PubMed ID: 3079049
    [No Abstract]   [Full Text] [Related]  

  • 12. There is no need to give blood transfusions as pretreatment for renal transplantation in the cyclosporine era.
    Groth CG
    Transplant Proc; 1987 Feb; 19(1 Pt 1):153-4. PubMed ID: 3079151
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine therapy and other adjuncts in the perioperative period with cadaveric and living related donor kidney transplantation.
    Milgrom M; Esquenazi V; Olson L; Fuller L; Roth D; Condie R; Kyriakides G; Miller J
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):8-11. PubMed ID: 3515699
    [No Abstract]   [Full Text] [Related]  

  • 15. Kidney graft survival in sensitized, cyclosporine A-treated recipients in Scandiatransplant.
    Jacobsen SE; Fjeldborg O; Madsen M; Lamm LU
    Transplant Proc; 1988 Jun; 20(3):365-6. PubMed ID: 3289162
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion.
    Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report.
    Henry ML; Tesi RJ; Elkhammas EA; Ferguson RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):689-90. PubMed ID: 8438438
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
    Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
    Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine and kidney graft survival: a review.
    Tiwari JL
    Clin Transpl; 1986; ():345-66. PubMed ID: 3154432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.